Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Operating-Income" stands at 54.36 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Eisai Co. Ltd.'s second quarter result of 11.24 Billion JPY for the item "Operating Income" represents a decrease of -45.82 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 11.24 Billion JPY for the item "Operating Income" represents an increase of 5.81 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 54.36 Billion JPY for the item "Operating Income" represents an increase of 1.15 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.35 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 8.35 Billion Japanese Yens.
The 3 year change is 56.27 Billion Japanese Yens.
The 5 year change is -73.20 Billion Japanese Yens.
The 10 year change is 25.97 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Income | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Income | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Income | 280,205,508,085.11 |